Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 17/20 | 0.43 |
| ▸ | JAK1 | P23458 | 16/20 | 0.43 |
| ▸ | TYK2 | P29597 | 14/20 | 0.43 |
| ▸ | JAK3 | P52333 | 14/20 | 0.43 |
| ▸ | STS | P08842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2277601 | 0.91 | JAK1 (0.45) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2277282 | 0.90 | JAK1 (0.44) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2278010 | 0.90 | JAK1 (0.44) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2278902 | 0.89 | JAK1 (0.44) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2272535 | 0.88 | JAK1 (0.45) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2273716 | 0.88 | JAK1 (0.43) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2275937 | 0.88 | JAK1 (0.46) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2277179 | 0.88 | JAK1 (0.43) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2272935 | 0.86 | JAK1 (0.41) | JAK2JAK1TYK2JAK3STS | |
| SCHEMBL2276488 | 0.86 | JAK1 (0.46) | JAK2JAK1TYK2JAK3STS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |